SK and M channel blockers have shown neuroprotective activity in different PD models (Salthun-Lassalle et al., 2004; Doo et al., 2010; Alvarez-Fischer et al., 2013; Paz et al., 2018; Table 2). The gene discussed is KCNN1; the disease is Parkinson disease.